Literature DB >> 11518067

Batch-to-batch reproducibility of St. John's wort preparations.

M Wurglics1, K Westerhoff, A Kaunzinger, A Wilke, A Baumeister, J Dressman, M Schubert-Zsilovecz.   

Abstract

Over the last few years, St. John's Wort products have enjoyed a tremendous surge in interest and sales for the therapy of mild to moderate depression. Although the complete spectrum of active substances in this herbal extract has not yet been elucidated, it is certain that hyperforin is an important component. Further, it appears that the hypericins may also contribute to the antidepressive activity. In this study, the content uniformity of eleven St. John's Wort products sold exclusively in pharmacies was determined. The main objective was to determine the batch-to-batch reproducibility of the various products. The hyperforin was analysed according to a previously published HPLC method, while the total hypericin content was determined by an electrochemical method. The results indicate that some, but not all, products show very reproducible batch-to-batch properties. Also, individual products have different hypericin and hyperforin levels, and are therefore not switchable--even when products are manufactured under similar extraction and processing conditions, have the same raw material:extract ratios (on a dry basis) and contain the same amount of extract per unit dosage form.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518067     DOI: 10.1055/s-2001-15453

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  6 in total

Review 1.  Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.

Authors:  Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Yanyan Cui; Catharina Y W Ang
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Phytochemical Assays of Commercial Botanical Dietary Supplements.

Authors:  Robert Krochmal; Mary Hardy; Susan Bowerman; Qing-Yi Lu; H-J Wang; Rm Elashoff; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

4.  Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis.

Authors:  Erich Seifritz; Martin Hatzinger; Edith Holsboer-Trachsler
Journal:  Int J Psychiatry Clin Pract       Date:  2016-05-10       Impact factor: 1.812

Review 5.  Clinical relevance of St. John's wort drug interactions revisited.

Authors:  Simon Nicolussi; Jürgen Drewe; Veronika Butterweck; Henriette E Meyer Zu Schwabedissen
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

6.  Investigation of impact of storage conditions on Hypericum perforatum L. dried total extract.

Authors:  Halil Koyu; Mehmet Zeki Haznedaroglu
Journal:  J Food Drug Anal       Date:  2015-05-20       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.